Upgrade naar
Pro
Log in / Registreer
Toggle navigation
Menu
Home
Koersen
Rendementen
Nieuws
Adviezen
Ratings
Sectoren
Analyses
Rapporten
Insiders
Short
Research
Mijn portefeuilles
Nieuws
Videos
Podcasts
Outlooks
Hot Topics
Bedrijven
Sectoren
Screeners
Research
Econ. nieuws
Short sell
Universiteit
Home
Bedrijven
The Edmond de Rothschild Group appoints a new Partner to its life science venture capital business
The Edmond de Rothschild Group appoints a new Partner to its life science venture capital business
9 januari 2014
Edmond de Rothschild Group / The Edmond de Rothschild Group appoints a new Partner to its life science venture capital business . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement. The Edmond de Rothschild Group today announced that Dr Naveed Siddiqi, has been appointed as a Partner, in its BioDiscovery venture capital funds franchise, effective December 2, 2013. Gilles Nobécourt, Raphael Wisniewski and Olivier Litzka, the three existing partners said: "We are delighted that Naveed has joined the Edmond de Rothschild Group. He brings 13 years of venture capital investment experience in companies focused on innovation. He will be joining the life sciences team to select new investment opportunities and supporting portfolio companies of the recently raised €192 million ($250 million) BioDiscovery 4 venture fund." Prior to joining the Edmond de Rothschild Group, Naveed was a Partner at Phase4 Ventures. His career spans medicine, investment banking and venture capital/growth equity. Before Phase4 Venture, he was part of a small initial founding group of investment professionals who helped to build a global healthcare investment business for Nomura with several hundred million dollars of invested capital. Naveed has been involved in over $1 billion of equity and debt financings in Europe, US and Japan. He has served as a Board director and observed on several Boards.  Prior to his career in private equity, he worked for EFG Corporate Finance, KPMG and UK's National Health Service. His academic qualifications include degrees in Medicine from Guy's & St Thomas's Hospital Medical School, London and accountancy from the Institute of Chartered Accountants, England & Wales. About the Edmond de Rothschild Group The Edmond de Rothschild Group is an independent, family-owned group specialising in asset management and private banking. Founded in 1953, the Group has been chaired by Baron Benjamin de Rothschild since 1997. As at 30 June 2013, it had CHF163 billion (€135.7 billion) in assets under management - with 2,900 employees and 30 offices worldwide. As well as asset management and private banking, the Group is active in corporate finance, private equity, and institutional & fund services. Press contact : Edmond de Rothschild Group Nathalie Tekadiomona + 33 [0]1 40 17 89 26 nathalie.tekadiomona@lcfr.fr Press Release (PDF): http://hugin.info/139296/R/1753800/591630.pdf This announcement is distributed by GlobeNewswire on behalf of GlobeNewswire clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Edmond de Rothschild Group via GlobeNewswire [HUG#1753800]
Abonneren op onze nieuwsbrief
Schrijf u gratis in voor ons beleggingsplatform met alles over aandelen, opties en ETF's. Meer dan 100.000 beleggers gingen u al voor.
If you are a human, ignore this field
Outlooks
Donderdag cijfers VS o.a. Ferrellgas Partners LP en Park City Group Inc
Donderdag EU-cijfers o.a. abrdn Property Income Trust Ltd en Enwell Energy PLC
Woensdag cijfers VS o.a. H.B. Fuller Company en Migom Global Corp
Tweets by @Analistbe
Duitse aandelenbeurs
Economische ontwikkelingen
5 redenen om bij LYNX te beleggen